J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sandeep PhadnisDesignation :- Company Secretary and Compliance Officer J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Closure of Trading Window
Closure of Trading WIndow JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings conference call J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Earnings conference call Transcript
Earnings Call for Q2FY22 of J B Chemicals & Pharmaceuticals
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript. JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting of extract of consolidated financial results for quarter ended on September 30, 2021 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended September 30, 2021
Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended September 30, 2021